Physician profile
Anil George
NPI 1609073782
$4,054.32
in general payments reported to CMS, 2019-2025
29 companies · $821 in 2025
The $821 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,158 · 2020: $212 · 2021: $460 · 2022: $234 · 2023: $451 · 2024: $718 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,930 · Education: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,930.08 |
| Education | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $638.16 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $519.19 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, V-Loc 180 |
| Abiomed | $450.46 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $321.14 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $203.91 | 2019-2025 | Rotapro, Watchman Access System, Avvigo Guidance System |
| Novartis Pharmaceuticals Corporation | $184.41 | 2019-2024 | |
| Amgen INC. | $177.93 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $171.23 | 2022-2024 | (Bh4) Igt Devices Undivided |
| Astrazeneca Pharmaceuticals LP | $165.39 | 2019-2024 | Andexxa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $160.58 | 2019-2024 | Lifevest |
| Abbott Laboratories | $148.37 | 2019-2025 | Xience Skypoint, Cardiomems, Navitor |
| Csl Behring | $130.68 | 2019-2024 | Kcentra |
| Pfizer INC. | $129.92 | 2019-2024 | |
| Shockwave Medical, INC | $103.48 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $98.82 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $96.89 | 2024 | Winrevair |
| Cardiva Medical, INC. | $68.88 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Medtronic Vascular, INC. | $65.18 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $46.78 | 2023 | Inpefa |
| Sanofi-Aventis U.S. LLC | $30.41 | 2019-2022 | |
| Biotronik INC. | $30.28 | 2019 | |
| Portola Pharmaceuticals, LLC | $22.13 | 2019 | |
| Bridgebio Pharma, INC. | $15.05 | 2025 | Attruby |
| Lantheus Medical Imaging, INC. | $14.69 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.68 | 2024 | Jardiance |
| Alexion Pharmaceuticals, INC. | $12.98 | 2021 | |
| Gilead Sciences, INC. | $12.94 | 2019 | |
| Cardinal Health 200 LLC | $11.76 | 2019 | |
| Penumbra, INC. | $9.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.